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Mahanine exerts in vitro and in 
vivo antileishmanial activity by 
modulation of redox homeostasis
Saptarshi Roy1, Devawati Dutta1, Eswara M. Satyavarapu1, Pawan K. Yadav2, Chhabinath 
Mandal3, Susanta Kar2 & Chitra Mandal1
Earlier we have established a carbazole alkaloid (mahanine) isolated from an Indian edible medicinal 
plant as an anticancer agent with minimal effect on normal cells. Here we report for the first time that 
mahanine-treated drug resistant and sensitive virulent Leishmania donovani promastigotes underwent 
apoptosis through phosphatidylserine externalization, DNA fragmentation and cell cycle arrest. An 
early induction of reactive oxygen species (ROS) suggests that the mahanine-induced apoptosis was 
mediated by oxidative stress. Additionally, mahanine-treated Leishmania-infected macrophages 
exhibited anti-amastigote activity by nitric oxide (NO)/ROS generation along with suppression of 
uncoupling protein 2 and Th1-biased cytokines response through modulating STAT pathway. Moreover, 
we have demonstrated the interaction of a few antioxidant enzymes present in parasite with mahanine 
through molecular modeling. Reduced genetic and protein level expression of one such enzyme 
namely ascorbate peroxidase was also observed in mahanine-treated promastigotes. Furthermore, 
oral administration of mahanine in acute murine model exhibited almost complete reduction of 
parasite burden, upregulation of NO/iNOS/ROS/IL-12 and T cell proliferation. Taken together, we have 
established a new function of mahanine as a potent antileishmanial molecule, capable of inducing ROS 
and exploit antioxidant enzymes in parasite along with modulation of host’s immune response which 
could be developed as an inexpensive and nontoxic therapeutics either alone or in combination.
Leishmania is an obligatory intracellular protozoan parasite responsible for the development of a spectrum of 
disease manifestation ranging from cutaneous to the more destructive visceral form1. Visceral leishmaniasis (VL) 
is a neglected tropical disease, mainly caused by the species L. donovani, which is prevalent in the Indian subcon-
tinent with 40,000 cases registered each year and 147 million people under the risk2.
Macrophages are the primary host for the parasite to survive and multiply in the mammalian system. 
Development of antileishmanial immunity depends on the Th1 type immune response generated by IL-12 secre-
tion by antigen presenting cells (APCs) which in turn induce IFNγ secretion by T cells. This secreted IFNγ further 
induce macrophages for generation of nitric oxide (NO) and reactive oxygen species (ROS), which are the major 
antileishmanial defense molecules3. Uncoupling protein (UCP) is a mitochondrial membrane transporter which 
takes part in the regulation of mitochondrial ROS generation in macrophages4. Leishmania developed several 
strategies to dodge the host immune response to the establishment of successful infection in the hostile environ-
ment. This parasite induces the expression of negative regulatory protein UCP2 in macrophages as well as utilizes 
their own cascade of antioxidant enzymes like ascorbate peroxidase (APX), glutathione synthetase, tryparedoxin 
peroxidase for the suppression of ROS generation thereby neutralizing oxidative stress in host for their survival5–8.
Due to unavailability of effective vaccines, treatment solely relies on chemotherapy. Although pentavalent 
antimonials were the mainstream therapy for past 70 years, a large percentage of patients are resistant to this drug. 
Currently, amphotericin B (conventional deoxycholate or liposomal formulations) has emerged as the first line 
of treatment. Miltefosine is the only oral drug. However, emerging resistance to miltefosine is particularly wor-
rying. Alongside, most of these synthetic antileishmanial drugs are highly expensive and suffer from various side 
effects, long treatment regimen and acute toxicity, thus pose a real challenge for the management and elimination 
1Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research (CSIR)-Indian 
Institute of Chemical Biology, 4, Raja S.C. Mullick Road, Jadavpur, Kolkata, 700032, India. 2Division of Parasitology, 
CSIR-Central Drug Research Institute, Lucknow, 226001, India. 3National Institute of Pharmaceutical Education and 
Research, Kolkata, 4, Raja S. C. Mullick Road, Kolkata, 700032, India. Correspondence and requests for materials 
should be addressed to C.M. (email: chitra_mandal@yahoo.com)
Received: 20 January 2017
Accepted: 12 April 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 7: 4141  | DOI:10.1038/s41598-017-03943-y
program of this poor man’s disease1, 9. With such a scenario, it becomes imperative to develop low-cost antileish-
manial molecules with minimal toxicity and immunomodulatory activity from the vast Indian natural resources 
as the armory of antileishmanial drugs are limited. Thus, an ideal antileishmanial molecule should possess the 
capability to target the parasite as well as to modulate the immune system of the host.
Mahanine, a carbazole alkaloid, was isolated from the leaves of an edible Indian medicinal plant Murraya 
koenigii abundantly available across the country10. Earlier work has established mahanine as a potent anticancer 
molecule against various cancers having different mutations with minimal toxicity towards normal cells both in 
vitro and in vivo10–17.
Miltefosine and cisplatin, two powerful anticancer agents, previously have been proved as potent antileish-
manial molecules18. However, the involvement of mahanine-induced cell death is not known in any parasitic 
disease. This led us to investigate the potency of mahanine against L. donovani. One of the main objectives of this 
study was to understand the efficacy and molecular mechanism of mahanine-induced apoptosis and targeting the 
antioxidant enzymes. Another major objective of our study was to investigate the in vitro and in vivo efficacy of 
mahanine for inducing effector molecules along with immunomodulation.
Here we provide evidence that mahanine induced antileishmanial activity both in promastigotes and amastig-
otes. Next, we have confirmed its potential activity in an acute murine model of leishmaniasis for almost complete 
clearance of the parasites along with upregulation of NO/iNOS/ROS/IL-12 and T cell proliferation. Moreover, 
we have demonstrated mahanine-mediated ROS generation which facilitates modulation of the ROS-generating 
pathway in Leishmania-infected macrophages and induced apoptosis. Furthermore, in-silico docking revealed 
that mahanine can interact with antioxidant enzymes present in L. donovani. To the best of our knowledge, this 
is the first report about the important role of this potent prooxidant molecule in inducing apoptosis both by 
targeting antioxidant enzyme of the parasite and altered immune regulation in the host for successful clearance 
of infection.
Results
Mahanine exhibited dose-dependent anti-promastigote activity and 7-AAD positivity. To 
determine the efficacy, the viability of mahanine-treated virulent drug sensitive and resistant L. donovani pro-
mastigotes (AG83 and GE1 respectively) was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxyme-
thoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt and phenazine methosulfate (MTS-PMS) solution, a 
modified MTT assay. Reduction in formazan production is due to decrease in mitochondrial activity indicating 
enhanced cell death. Mahanine (0–50 µM) induced a dose-dependent decrease in cell viability of AG83 promas-
tigotes after 24 hr and 48 hr; the IC50 values were 16.7 ± 1.7 µM and 11.5 ± 0.8 µM respectively (Fig. 1b). In a drug 
resistant GE1 strain, mahanine treatment showed dose-dependent cell death in 24 and 48 hr treatment with IC50 
values 40.3 ± 2.2 µM and 29.1 ± 1.3 µM respectively (Fig. 1b). Ethanol was used as the vehicle control and dis-
played no apparent toxicity on the both the parasite strains.
Apoptosis or necrosis resulted in membrane damage and increased positivity of 7-Aminoactinomycin D 
(7-AAD), a DNA binding dye. Thus increased 7-AAD positivity also indicates the cell death. Mahanine (10 µM) 
treatment resulted in 20.5% 7-AAD positivity while at 30 µM dose it was 96.7% indicating the complete death of 
AG83 promastigotes (Fig. 1c).
Mahanine-mediated alteration of phosphatidylserine and PI positivity. Annexin V has the affinity 
towards phosphatidylserine, a key molecule in apoptotic signaling. Propidium iodide (PI) is a DNA binding dye. 
As annexin V positivity is the early event during apoptosis, this assay was performed with the lower doses than 
IC50.
Annexin V positivity was increased to 22.72 ± 1.84% and 27.0 ± 2.06% in mahanine (5.0 µM and 
7.5 µM)-treated cells with low PI positivity (4.37 ± 0.91% and 7.78 ± 1.07%) respectively after 24 hr. At the 10 µM 
dose, PI positivity further increased to 12.66 ± 1.91%, indicating promastigotes are entering into the late apop-
totic phase (Fig. 1d). Untreated log phase promastigotes exhibited no binding with annexin V.
DNA degradation in the mahanine-treated promastigotes. Degradation of nuclear DNA by endog-
enous nuclease gives the characteristic DNA laddering, which is one of the hallmarks of apoptotic cell death. 
Genomic DNA isolated from untreated promastigotes exhibited as a tightly packed band near the loading well 
and barely moved (Fig. 1e). However, DNA isolated from mahanine (10–30 µM)-treated cells were fragmented. 
No packed and coiled DNA was visible at 40 µM dose.
Mahanine induced cell cycle arrest at G2/M phase. The percentage of cells in the different phase of 
the cell cycle was quantified by using PI and a number of bound dye correlates with the DNA content. Mahanine 
(5.0 and 10 µM)-treated cells exhibited increased accumulation of cells at G2/M phase being 39.0 ± 1.90% and 
41.0 ± 2.10% respectively compared to untreated promastigotes (35.3 ± 2.60%), while the number of cells at G0/
G1 phase were decreased at 10 µM than control. At a higher dose, cell population decrease in G2/M and it moved 
to apoptosis. A representative flow diagram of cell cycle arrest along with the percentage of the cell population is 
shown in Fig. 1f.
Mahanine induced intracellular ROS in promastigotes. Mahanine has already been proved as a 
potent generator of ROS at an early time point in cancer cells16. So the efficacy of mahanine in ROS generation 
was assessed in promastigotes (AG83). Mahanine (25 µM)-treated cells exhibited significantly increased intracel-
lular ROS level within 20 min (MFI being 889 ± 26) which reached to 1288 ± 56 after one hour compared to the 
basal level (604 ± 34) in untreated promastigote (Fig. 2a).
Based on this result, 45 min timing was selected for ROS generation to optimize the dose. ROS generation 
was significantly increased MFI being 913 ± 115 and 1237 ± 130 (p ≤ 0.01) when 20 µM and 30 µM of mahanine 
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was used (Fig. 2b) compared to untreated cells (649 ± 40). Pre-treatment of cells with the glutathione precursor 
N-acetyl cysteine (NAC) successfully inhibited the mahanine (30 µM)-induced ROS level from 1237 ± 119 to 
929 ± 59.
Mahanine-induced ROS contributed to cell death. Next, we were keen to examine the role of this intra-
cellular stress by mahanine-induced ROS in the cell death of promastigotes. Accordingly, mahanine-mediated cell 
death of parasites was assessed by PI staining in the presence and absence of NAC, the ROS scavenger, after 24 hr.
Figure 1. Mahanine triggered apoptotic-like events in virulent promastigotes of L. donovani. (a) Structure of 
mahanine. (b) Exponentially growing SAG sensitive and resistant strain AG83 and GE1 promastigotes (1 × 105) 
were plated in each well and incubated with either 1% absolute ethanol (vehicle control) or mahanine (5–
100 µM) for 24 and 48 hr at 22 °C. MTS-PMS (5:1) was added and cell viability was measured in ELISA reader 
at 495 nm. (c) Log phase promastigotes (2 × 106/well) were incubated with mahanine (0–30 µM) for 24 hr at 
22°C. 7-AAD positivity was quantified by FACS. (d) Parasites (2 × 106/well) were either treated with vehicle or 
mahanine (5.0–10 µM) for 24 hr. Annexin V-PI positive cells were quantified in a flow cytometer. (e) Genomic 
DNA was extracted from mahanine and absolute ethanol (1%)-treated parasites. DNA was separated on 1% 
agarose gel and visualized with ethidium bromide. (f) AG83 promastigote were exposed to either vehicle control 
or mahanine (5–15 µM) for 24 hr and processed using cell cycle analysis kit. Histograms showed the distribution 
of DNA content in each stage of cell cycle.
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Mahanine (10 µM and 15 µM) induced 18.85 ± 1.39% and 26.06 ± 2.25% PI positivity in promastigotes which 
showed a significant (p ≤ 0.001) reduction (7.15 ± 1.12% and 10.97 ± 1.44% respectively) of PI positivity in pres-
ence of NAC (Fig. 2c). Thus NAC rescued the effects of the mahanine-induced cell death to a level of ~ 72% sug-
gesting an initial important role of ROS in the mahanine-induced apoptosis of these virulent parasites (Fig. 2d).
Mitochondrial membrane depolarization in mahanine-treated promastigotes. The 
enhanced production of ROS increased the option that mitochondrial function may be changed. Accordingly, 
we measured the membrane potential in mitochondria using 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraet
hylbenzimi-dazolylcarbocyanine iodide (JC1). The enhanced green fluorescence indicated the loss of mitochon-
drial membrane potential. Mahanine-treated promastigotes exhibited dose-dependent upregulation of the green 
fluorescence. It increased the green fluorescence (MFI 1258 ± 119) in promastigotes compared to untreated cells 
(MFI 641 ± 42) after 24 hr treatment at 10 µM dose. At the higher doses (25 and 30 µM), the MFI of green fluores-
cence was further increased to 2478 ± 109 and 3000 ± 206 respectively (Fig. 2e).
Figure 2. Mahanine-mediated mitochondrial dysfunction, ROS generation, and ROS-dependent cell death in 
AG83 virulent promastigotes. (a) Promastigotes (2 × 106) were preloaded with H2DCFDA (50 µM) and plated 
in a six-well plate. The IC90 dose of mahanine (25 µM) was used at different time points (0–1 hr). H2DCFDA 
positivity was measured by FACS. (b) Promastigotes were preloaded with H2DCFDA and treated with 
mahanine (0–30 µM) for 45 min. For the highest concentration of mahanine (30 µM) treatment, promastigotes 
were pretreated with NAC (20 mM). Cells were acquired in FACS and analyzed. (c) Promastigotes (2 × 106) 
were either untreated or treated with NAC (20 mM) and incubated with mahanine (0–15 µM) for 24 hr at 
22 °C. Promastigotes were stained with PI and analyzed in FACS. (d) A representative image was shown by a 
histogram. (e) Promastigotes were either treated with ethanol (1%) or mahanine (0–30 µM) for 24 hr at 22 °C.
Parasites were incubated with JC1 for 30 min, processed and analyzed by FACS.
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Mahanine reduced the intracellular amastigote number in infected macrophages. Promastigotes 
are readily phagocytosed by the macrophages into the phagolysosomal vacuole and converted into the nonmotile 
amastigotes form which is replicative inside the mammalian cells. Accordingly, we were keen to examine whether 
mahanine also could kill these intracellular infectious form of the parasite.
Mahanine reduced the amastigotes number in infected macrophages in a dose-dependent manner. A signif-
icant decrease was observed when mahanine was used at 5.0 µM, 10 µM and 20 µM doses; values being 402 ± 33 
(p ≤ 0.05), 239 ± 32 (p ≤ 0.01) and 46 ± 11 (p ≤ 0.001) respectively compared to 573 ± 61 in untreated infected 
macrophages (Fig. 3a). The IC50 value of mahanine against amastigote was of 8.94 ± 1.20 µM. A representative 
image of Giemsa staining of infected macrophage in the index of the graph also showed a very low number of 
amastigotes as pink dots. However, under the similar condition, the viability of macrophages was ≥93% even 
when highest dose of mahanine was used.
Induction of Th1 dominant cytokines in mahanine-treated infected macrophages. Leishmania 
infection is associated with the Th2-dominated cytokine response which causes the immune suppressive condi-
tion in the host. IL-10 and IL-4 are two major immune suppressive cytokines associated with VL. IFNγ is the Th1 
cytokine which gives protection in VL and generally down regulated during infection. To examine whether the 
mahanine-induced antileishmanial activity was also due to alteration of host’s cytokine response, we investigated 
the cytokine production inside the infected macrophages before and after treatment with mahanine.
IFNγ secretion dose-dependently increased in mahanine-treated infected macrophages compared to 
untreated cells (Fig. 3b). At the 5.0 µM, 10 µM and 15 µM doses, the IFNγ secretion increased significantly to 
239 ± 65 pg/ml, 513 ± 83 and 756 ± 61 pg/ml respectively compared to untreated cells (87 ± 17). In contrast, IL-10 
secretion reduced to 462 ± 38 pg/ml, 333 ± 51 and 201 ± 12 pg/ml at 5.0,10 and 15 µM of mahanine compared to 
601 ± 40 pg/ml during infection. The basal level of IL-10 in uninfected cells was only 215 ± 33 pg/ml. Similarly 
mahanine (5.0 and 15 µM) also decreased the level of another Th2 cytokine (IL-4) significantly to 623 ± 35 pg/ml 
(p ≤ 0.001) and 330 ± 29 pg/ml (p ≤ 0.001) in infected macrophages compared to 953 ± 132 pg/ml in untreated 
cells.
Figure 3. In vitro efficacy of mahanine. (a) Murine macrophage cell line J774A.1 (2 × 104) grown in 22mm2 
glass cover slip were infected with stationary phase virulent AG83 promastigotes (1: 10) for 4 hr. Unbound 
parasites were removed and infection was allowed for another 20 hr. Infected cells were treated with mahanine 
(0–20 µM) for 24 hr. Macrophages were fixed and stained with Giemsa. Intracellular parasites were counted 
in a light microscope. The values represented as a mean of three independent experiments. A representative 
image was given as micro photo above the mean value. (b) Macrophages (J774A.1, 1 × 106/well) were infected 
with stationary phase L. donovani (AG83) promastigotes similarly as stated above. The secreted cytokines (IL-4, 
IL-10, and IFNγ) in the culture supernatants were measured by respective ELISA kit as described in material 
and methods. (c) J774A.1 cells (1 × 106/well) were infected and treated similarly as stated above. The cell 
lysate was prepared; proteins were quantified, separated in SDS-PAGE. They were transferred to nitrocellulose 
membrane and incubated overnight with anti-STAT1, p-STAT1, STAT-4, STAT3, p-STAT3 and α-tubulin 
antibodies. The blots were incubated with respective secondary antibody and developed by ECL kit. α-tubulin 
was used as a control. (d) J774A.1 cells (1 × 106/well) were either uninfected or infected with promastigotes 
and treated with mahanine (0–15 µM) for 24 hr similarly as stated earlier. The NO secretion was measured in 
the culture supernatant by Griess reaction. (e) J774A.1 cells (1 × 106/well) were left uninfected or infected with 
promastigotes at 1:10 ratio for 4 hr. Cells were incubated with mahanine (0–30 µM) for 1 hr and Intracellular 
ROS production was measured after H2DCFDA staining by FACS. Data was analyzed by CellQuestPro software. 
(e) J774A.1 cells were infected with AG83 promastigotes similarly as stated above and cell lysate was prepared. 
The lysate was run in gel, incubated with specific anti-SHP-1, anti-UCP 2, anti-p-p3MAPK, anti-p38MAPK, 
anti-p-ERK1/2 antibodies and developed similarly. α-tubulin was used as loading control.
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Mahanine exhibited modulation of STAT signaling pathway. Mahanine shifted Th1-biased response 
by modulating the Th1/Th2 cytokine balance in the infected macrophages. This led us to investigate the cytokine 
signaling STAT pathway (Fig. 3c). During Leishmania infection, there was a reduced expression of p-STAT1, a 
well-known transcription factor of IFNγ. However, mahanine exhibited a dose-dependent increase of p-STAT1 
level in the Leishmania-infected macrophages, while total STAT1 remained unaffected. Similarly STAT4, the tran-
scription factor of another Th1 cytokine (IL-12), also showed dose-dependent upregulation in mahanine-treated 
infected cells compared to untreated infected cells. In contrast, mahanine down regulated the expression of 
STAT3 and p-STAT3, a transcription factor of Th2 cytokine (IL-4) in dose-dependent manner.
Enhanced nitric oxide (NO) production in mahanine-treated infected macrophages. To fur-
ther elucidate whether mahanine induces host’s immune alteration in the infected macrophages for its antileish-
manial effect, the production of an effector molecule NO was assessed. In general, NO content was reduced 
(9.5 ± 1.50 nM) in infected macrophages compared to uninfected cells (12.4 ± 0.78 nM). However, mahanine 
(5.0 µM)-treated infected macrophages exhibited enhanced NO level (16.86 ± 0.61 nM, p ≤ 0.01) in the cul-
ture supernatant. A higher dose of mahanine (10 and 15 µM) further increased its level to 24.53 ± 1.98 and 
31.36 ± 1.36 nM respectively (p ≤ 0.001) (Fig. 3d).
Mahanine dose-dependently upregulated ROS in the infected macrophages. ROS is another key 
molecule involved in antileishmanial defence. Thus any prooxidant agent having the capability to modulate the 
macrophages for ROS generation can be an effective antileishmanial agent. Promastigote-infected macrophages 
in general enhanced its ROS level compared to uninfected cells, MFI being 205 ± 33 vs.117 ± 12 respectively. 
However, mahanine (10 µM)-treated infected macrophages further upregulated ROS level (342 ± 59, p ≤ 0.05), 
which subsequently augmented to 400 ± 37 and 459 ± 62 (p ≤ 0.01) when doses were increased to 15 and 20 µM. 
At the highest dose (30 µM), there was a drop in the ROS production, indicating 20 µM is the optimum concen-
tration for ROS production (Fig. 3e).
Mahanine modulated ROS-generating pathway in the infected macrophages. We have already 
established that mahanine induced ROS in the infected macrophages. As UCP2 is negatively regulated by 
Leishmania to inhibit mitochondrial ROS production, we have further investigated whether mahanine can inhibit 
this molecule.
Indeed we observed down regulation of both UCP-2 and SHP-1 in mahanine-treated infected cells in a 
dose-dependent manner compared to untreated infected cells. Another two signaling molecules (p38MAPK and 
p-ERK1/2) are generally targeted by SHP-1. Accordingly, we have also monitored their status in mahanine-treated 
cells. We demonstrated upregulation of both p-p38MAPK and p-ERK1/2 compared to untreated infected cells 
indicating probability to induce the Th1 response (Fig. 3f).
Molecular modeling studies of mahanine with antioxidant enzymes. Since Leishmania encounter 
various oxidative stresses during its life cycle, its defense arsenal is enriched with many antioxidant enzymes8. 
As mahanine induces ROS and ROS-mediated cell death both in virulent promastigotes and amastigotes, it was 
worthwhile to test whether it can target any of these anti-oxidant enzymes of the parasite. As a preliminary study, 
we performed molecular docking between mahanine and six major antioxidant enzymes of L. donovani to exam-
ine their affinity and pose of binding (Table 1).
Accordingly, three-dimensional structures of all six antioxidant enzymes of L. donovani were built using 
homology modeling, based on the identified templates described in Materials and methods section (Table 1, 
Fig. 4a, Supporting information Fig. S1A–E). The energy-optimized modeled structures of these antioxidant 
enzymes showed that the geometry of the main chain was very well favoured in the Ramachandran plot (Fig. 4b, 
Supporting information Fig. S1A’–E’).
The modeled structure of APX consists of α/β motifs and has RMSD value of 0.10 Å on structural super-
position with the template, 3RIV (Fig. 4a, Table 2). Cytoplasmic and mitochondrial tryparedoxin peroxidase 
comprised a typical thioredoxin fold that contains a central β-sheet and surrounded by α-helices (Supporting 
information Fig. S1A,B). However, superoxide dismutases and HSP83 consist of mainly α-helices, with some 
β-sheets in between (Supporting information Fig. S1C–E). Structural validation of all these six enzymes showed 
that Φ and Ψ backbone torsion angles of most of the non-glycine residues were within the most favoured area, 
Antioxidant enzymes
Template 
(from PDB) Similarity e-value
Ascorbate peroxidase 3RIV 96% 0.0
Tryparedoxin peroxidase 
(cytoplasmic) 3TUE 90% 7e-136
Tryparedoxin peroxidase 
(mitochondria) 4KB3 89% 2e-127
Superoxide dismutase (FESODA) 4F2N 93% 2e-161
Superoxide dismutase (FESODB1) 3ESF 70% 2e-101
Hsp83 3HJC 96% 0.0
Table1. Template identification of six antioxidant enzymes of L. donovani on the basis of sequence similarity 
and e-value.
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with a few residues in additionally allowed regions. Either one or none of the residues (in some cases) was present 
as outliers (Table 2, Fig. 4b, Supporting information Fig. S1A′-E′). Structural superposition with the template 
also showed small RMSD values (less than 1.0 Å). Moreover, the verify3D program which describes the overall 
quality factor and compatibility of an atomic model (3D) with amino acid sequence (1D) for the modeled protein, 
showed that more than 80% of the amino acid residues had an averaged 3D-1D score>=0.2, thus satisfying the 
standard criteria. The overall geometric environment profile calculation of the model determined by the ERRAT 
program has a good score (Table 2).
Molecular docking studies showed that the APX binds to mahanine with higher affinity. However, there are 
other antioxidant enzymes whose binding affinities are close to that of APX (Table 3, Fig. 4c, Supporting infor-
mation Fig. S2A–E). This can be attributed to the multi-target nature of mahanine. The location of binding of 
Figure 4. Molecular modeling, genetic and protein level expression profile of ascorbate peroxidase (APX) 
of L. donovani with mahanine. (a) Modeled structure of L. donovani APX with bound HEM group in the 
active site. The structure is displayed in ribbon form where colours are represented as (sheets = dark blue, 
helices = magenta and loop = grey). HEM moiety is represented in sticks in red color and Fe2+ in orange. (b) 
Ramachandran plot of the modeled structure. (c) Docked complex of mahanine with ascorbate peroxidase. 
The ligand is represented in sphere form where C = green, O = red, N = blue and H = white. The protein 
is represented both as a partial Connolly surface in tan color and ribbon form with helices (magenta) and 
sheets (dark blue). (d) Close view of mahanine bound in the active site of the enzyme; mahanine is in close 
proximity to the HEM. Mahanine and HEM are represented in stick model. (e) Amino acid residues of 
ascorbate peroxidase interacting with mahanine involving H-bond and van der Waals interactions. Both 
residues and the ligand represented as stick model where colors are highlighted as [carbon (APX) = tan, carbon 
(mahanine) = green, carbon (HEM) = red, oxygen = red, nitrogen = dark blue, Fe2+  = orange]. (f) The cell 
lysate was prepared from mahanine (0–20 µM)-treated log phase promastigotes (2 × 107) for 24 hr and run 
in SDS-PAGE (12%). The blot was incubated with antibody against ascorbate peroxidase and β-tubulin and 
developed similarly. (g) Promastigotes were treated similarly as stated above and total RNA was isolated. cDNA 
was prepared, PCR performed using a specific primer of APX and α-tubulin and run in a gel. The image was 
visualized and photographed in Bio-Rad Gel Documentation system.
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mahanine is close to HEM group of APX and interacts with a few amino acid residues through non-covalent weak 
interactions (Fig. 4d,e).
Based on these observations, we have selected one such enzyme namely APX for our subsequent 
study. Accordingly, we monitored the level of APX in mahanine-treated promastigotes after 24 h (Fig. 4f). 
Mahanine-treated cells exhibited a dose-dependent reduction in the protein level at 10 µM compared to untreated 
cells. At the highest dose (20 µM), APX expression was completely absent, indicating the total suppression of this 
protein by mahanine treatment. β-tubulin was used as loading control. Furthermore, mahanine-treated virulent 
promastigotes also showed reduced genetic expression of APX level in a dose-dependent manner (Fig. 4g). The 
loading control α-tubulin level remains unchanged before and after mahanine treatment.
Mahanine exhibited reduced intracellular parasite burden in infected mouse model via induc-
tion of NO/iNOS/ROS/IL-12 and T cell proliferation. So far we have successfully demonstrated that 
mahanine exerts strong cytotoxicity and induces apoptosis through enhancing the intracellular ROS level both in 
promastigotes and amastigotes in infected macrophages and leading to decrease the level of antioxidant enzymes. 
Next, we investigated whether mahanine is capable of clearing intracellular parasite load in infected mice, a 
well-established acute model to control Leishmania infection. Here we have validated the efficacy of mahanine in 
vivo which corroborated the in vitro results.
Initially, infection was established in Balb/c mice with virulent AG83 promastigotes and subsequently fed 
these infected animals with 20 and 40 mg/kg b.w/day of mahanine for 5 consecutive days. Animals were sacrificed 
4 days after the last feeding and examined. Fed animals were healthy and no change in body weight was observed. 
At 20 mg/kg b.w /day dose of mahanine there was 89.1 ± 4.1% reductions in parasite burden in spleen and this 
decline was almost complete (96.2 ± 0.3%) at 40 mg/kg b.w/day dose even after four days post treatment (Fig. 5a). 
Standard drug miltefosine also showed complete clearance (~99%) of parasite burden from the infected spleen. 
A representative image of infected and treated (mahanine and miltefosine) mice splenic tissue is shown in the 
Fig. 5b.
Mahanine induced modulation of effector function in the infected murine model was tested to further estab-
lish the role of mahanine in effector molecule generation. Accordingly, we checked the efficacy of mahanine in NO 
generation in the culture supernatant of these murine splenocytes isolated from infected untreated and treated 
groups. Splenocytes in the 20 and 40 mg/kg b.w/day treated mice showed 2.53 ± 0.60 µM and 4.861 ± 0.88 µM 
nitrite level compared to corresponding infected (1.31 ± 0.36) and uninfected control (Fig. 5c). The efficacy of 
mahanine in ROS generation in murine splenocytes isolated from infected untreated and treated groups was 
evaluated. We observed upregulation of ROS level to 449 ± 61 and 347 ± 52 MFI units compared to those isolated 
from infected mice which showed the basal level of ROS (Fig. 5d).
Leishmania infection impaired the T cell proliferation and therefore any ideal antileishmanial molecule should 
promote lymphocyte proliferation to reduce the parasite burden. Almost complete remission of parasite burden 
and induction of microbicidal molecules interested us to study the mahanine-induced cell-mediated immunity 
by measuring T cell proliferation. As expected, infected murine splenocyte showed 65% reduction of T cell pro-
liferation than uninfected control. However, mahanine-treated mice exhibited 37% and 52% fold increased T cell 
proliferation than infected splenocytes (Fig. 5e).
Antioxidant enzymes
Favoured 
region (%)
Allowed 
region (%)
Outliers 
(%)
RMSD with 
template (Å)
Verify3D 
program
Errat program 
(%)
Ascorbate peroxidase 99.2 0.8 Nil 0.10 90.98 96.51
Tryparedoxin peroxidase (cytoplasmic) 98.5 1 1 0.41 96.46 80.0
Tryparedoxin peroxidase 
(mitochondria) 98.2 1.8 Nil 0.32 80 71.43
Superoxide dismutase (FESODA) 98.1 1.9 Nil 0.12 89 80.0
Superoxide dismutase (FESODB1) 97.9 1.6 1 1.00 100 70.05
Hsp83 98.5 1.2 1 0.33 89 88.0
Table 2. Structure validation of the modeled structure of six antioxidant enzymes of L. donovani using different 
validation programs.
Antioxidant enzymes
Binding energy (ΔGbind)
Kcal/mol
Ascorbate peroxidase −7.77
Tryparedoxin peroxidase (cytoplasmic) −6.58
Tryparedoxin peroxidase (mitochondria) −6.94
Superoxide dismutase (FESODA) −5.76
Superoxide dismutase (FESODB1) −5.85
HSP83 −6.99
Table 3. Free Energy Values of docked complexes of mahanine with antioxidant enzymes of L. donovani.
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We observed enhanced Th1 type response in mahanine treated-infected macrophages in vitro which is nec-
essary to resolve the Leishmania infection. As IL-12 is the key cytokine that induces Th1 cell proliferation, we 
tested the efficacy of mahanine in murine splenocytes by real time PCR. We found mahanine-fed mice resulted in 
3.49 and 4.84 fold increase of IL-12 in mRNA level at both the doses as compared to only 0.61 fold in the infected 
Figure 5. In vivo efficacy of mahanine in mice. (a) Female Balb/c mice were infected with stationary phase 
virulent AG83 promastigotes. Infection was established for 15 days and fed with vehicle control (DMSO) or 
mahanine or miltefosine for five consecutive days. Mice were sacrificed after four-day post feeding and splenic 
parasite burden was measured by stamp-smear method after Giemsa staining. (b) Giemsa-stained infected and 
treated splenic smears bearing amastigotes as indicated by white arrow (100 X under oil immersion lens). The 
slides were viewed and the image captured on an inverted bright-field microscope (IX73 inverted microscope; 
Olympus). (c) Splenocytes isolated from infected untreated and treated groups of mice were incubated 
for 3 days in presence of SLA and supernatant was collected. Nitrite was quantified by Griess reaction. (d) 
Splenocytes isolated from infected and treated groups were plated (1 × 106/ml) in a six-well plate and incubated 
for 48 hr in presence of SLA. ROS generation was measured by adding H2DCFDA in FACS. (e) Splenocytes 
from control and fed mice were plated in a 96 well plate and incubated for 3 days in presence of SLA. Cell 
proliferation was measured by MTT. (f) Total RNA was isolated from infected untreated and treated mice 
splenocytes and cDNA were prepared. cDNA was amplified by real-time PCR by using specific primers from 
IL-12 and iNOS and represented as fold changes compared to control. HGPRT was used for normalization.
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murine splenocytes indicating the boost in cell-mediated immunity (Fig. 5f). As IL-12 production ultimately 
leads to the enhancement of effector function, we have tested the mRNA expression level of NO synthase gene, 
iNOS. Consistent with our NO generation data, the iNOS mRNA were significantly upregulated (1.80 and 3.48 
fold) after 20 and 40 mg/kgb.w/day mahanine treatment compared to infected control (0.68 fold) (Fig. 5f).
Discussions
Visceral leishmaniasis is still one of the deadly parasitic diseases accounting for significant morbidity and mor-
tality in the Indian subcontinent. As VL is poor man’s disease, the pace of drug development is far away from the 
requisite perimeter. Most of the marketed antileishmanial drugs are highly toxic and expensive, keeping them out 
of the grasp of rural India19, 20. Widespread drug resistance is another difficult problem to tackle the disease21. In 
this context, development of antileishmanial molecule from our vast natural sources is worthwhile.
A carbazole alkaloid, mahanine, has already been established as a potent anticancer molecule against different 
types of cancer cells both in vitro and in vivo with minimal toxicity to normal cells17. The main achievement of the 
present study is to introduce this molecule which exhibited for the first time the anti-proliferative effect on drug 
sensitive and resistance virulent L. donovani promastigotes as well as human infected form amastigotes. Here, 
we demonstrated the underlying involvement of the various apoptotic-related molecules in mahanine-treated 
promastigotes through ROS production. We have also shown that mahanine interact with antioxidant enzymes 
which are involved in ROS generation in L. donovani through in-silico approach. The accumulated ROS further 
decreased the level of one such antioxidant enzyme (APX). Additionally, mahanine activated the effector mole-
cules (ROS and NO) and also altered immune regulation in infected macrophages for successful clearance of par-
asite. Taken together, we have for the first time demonstrated the effectiveness of a nontoxic novel herbal molecule 
as an antileishmanial agent conclusively confirmed by both in vitro and in vivo experiments.
Apoptosis is the predominant form of program cell death in Leishmania22. Here we report that mahanine is 
inducing a few hallmark of apoptotic events such as membrane flipping, cell cycle arrest and DNA degradation 
in L. donovani parasites. In both prokaryotic and eukaryotic organisms, mitochondria play a pivotal role in ROS 
generation which could induce cellular redox imbalance and ultimately leads to apoptosis23. ROS initiates at the 
early phase of apoptosis, followed by thiol depletion and cell death24. Mahanine exhibited the mitochondrial 
depolarization which can also lead to the ROS generation in infective stage of the parasite. It induced a significant 
amount of ROS even at early time point leading to the cell death. The reversal of mahanine-induced apoptosis by 
glutathione precursor, NAC established the critical role of ROS in this event.
As Leishmania is an intracellular form of parasite and amastigote is the infective form in the mammalian 
host, so the efficacy of mahanine was further tested against amastigotes. It showed a dose-dependent reduc-
tion in the intracellular amastigotes. To establish a successful infection, L. donovani induces immunosuppressive 
effect which could lead to deactivation of macrophages effector function. Therefore, an effective antileishmanial 
response should generate a dominant Th1 response25. Mahanine exhibited a dose-dependent increase in IFNγ 
level in infected macrophages which are corroborated with the gradual decrease in IL-4 and IL-10 associated with 
immunosuppression suggesting its antileishmanial capacity.
For further validation, we have also tested the status of a major signaling pathway regulating the cytokine 
secretion. IL-12 can mediate Th1 response leading to IFNγ secretion during Leishmania infection26. STAT1 and 
STAT4 being transcription factors of IFNγ and IL-12 respectively are well correlated with enhanced IFNγ levels 
in mahanine-treated infected macrophages. In contrast, L. donovani induces STAT3 expression during infec-
tion, which is the inducer of a major immune suppressive cytokine (IL-10)27. Downregulation of p-STAT3 in 
mahanine-treated infected macrophages is further confirming the reversal of immunosuppressive condition con-
firming critical role of mahanine in the modulation of host’s cytokine response in clearance of the parasite.
IFNγ secretion has a dominant effect on NO production28. This was corroborated by the increased nitrite gen-
eration by mahanine in the infected macrophages. ROS generation in the host cell is either through a by-product 
of the cellular metabolism of oxygen or disruption of mitochondrial electron transport chain. Our compound 
has earlier been proved to be a potent ROS generator through inhibition of complex III of ETC in cancer cells12. 
Mahanine also produced a significant amount of ROS within 1 hr in parasite infected macrophages.
The parasite also can modulate the production of mitochondrial ROS in the macrophages by strong upreg-
ulation of a mitochondrial inner protein UCP2, a negative regulator5. Induction of this molecule upregulates 
the phosphatase activity of macrophage which in turn suppresses p38 and ERK1/229, 30. Here we have demon-
strated the mahanine induced decrease in UCP2 molecule in the infected macrophages which are further linked 
to reduced SHP-1 level. Upregulation of p38 and ERK1/2 indicated the enhanced probability of induction of 
inflammatory response which could be correlated with Th1 type cytokine response and augmented effector func-
tions for clearance of parasites.
Leishmania encounters various oxidative stresses in the host cells thus they express several antioxidant enzyme 
cascades for their survival in the host7. Due to the absence of selenium-dependent glutathione peroxidase, 
tryparedoxin is one of the major enzymes reported to be a virulent protein in Leishmania to neutralize oxida-
tive insult31. Therefore this may be considered as a potent drug target32. Ascorbate peroxidase in another major 
antioxidant enzyme reported to function during oxidative burst for parasite survival33. The parasite also utilizes 
superoxide dismutase and heat shock proteins for as their defence arsenal34, 35.
Mahanine being a prooxidant agent induces ROS and ROS-mediated cell death both in virulent promastigotes 
and amastigotes, therefore it was worthwhile to test whether it can target anti-oxidant enzymes of the parasite. 
Computational approach has provided several methods for protein structure prediction and characterization of 
binding sites, studying the dynamic nature of drug targets and affinity of the protein-ligand complex36. Therefore, 
as a preliminary study, we attempted to determine the strength of binding of mahanine to these enzymes and 
their preferred orientations in the binding pockets through in-silico approach. Currently, we are in a process of 
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in-depth study to validate such computational prediction to compare the involvement of all the related antioxi-
dant enzymes of the parasite in their clearance. Such studies are ongoing.
The therapeutic efficacy of mahanine was successfully corroborated in acute murine models of experimental 
visceral leishmaniasis. However, there is a limitation for using Balb/c mice due to the differences in clinicopatho-
logical features than the active human disease37. Hamsters are the good animal model that mimics human infec-
tion; however, non-availability of immunological tools restricts its use. As the longer duration of infection in mice 
induces a cellular response that inhibits parasite growth, we have used 15 days model of infection which provide 
all the immunological features similar to human. Oral feeding of mahanine for only five consecutive days showed 
almost complete remission of spleen parasite burden indicating the potency of this molecule. In vivo mahanine 
treatment also associated with strong induction antileishmanial effector molecules, enhanced IL-12 response 
and T cell proliferation indicating the boost in cell-mediated immunity. The nontoxic nature of this prooxidant 
molecule might give an additional advantage over synthetic drugs due to its capacity to modulate host’s immune 
response.
Most of the currents used antileishmanial drugs mainly act through directly targeting the parasite without 
rejuvenating the host immune response and showed significant toxicity in the tissues1, 38. Although miltefosine 
has immunomodulatory activity, it is associated with acute toxicity like teratogenicity and abortifacient nature 
with a long median half-life9. More importantly, it is very expensive and therefore beyond the reach of most of the 
patients together with emerging drug resistance. As herbal compounds show a great deal of promise as chemo-
therapeutic agents against a variety of diseases, we propose mahanine as an alternative inexpensive source since 
it is nontoxic to normal cells and different organs with no loss of body weight in experimental animals17. Thus 
mahanine might have extra advantages of being nontoxic, inexpensive and isolated from an abundantly available 
plant.
Taken together our in-depth study conclusively ascertains the function of mahanine on both drug sensitive 
and drug resistant virulent parasites and has the potential to clear parasite burden in vivo. Therefore, we propose 
the introduction of this nontoxic herbal molecule as a potential antileishmanial agent. There is also the opportu-
nity to use this herbal remedy as a combinational chemotherapeutic agent along with traditional antileishmanial 
drugs.
Materials and Methods
Reagents and mice. DMSO and Giemsa stain were purchased from Sigma (MO, USA); MTS-PMS assay 
kit was from Promega (WI, USA); Apoptotic DNA Ladder Kit was from Roche (Basel, Switzerland); JC1 dye was 
from ThermoFisher Scientific (OR, USA), H2DCFDA was from Molecular probes (OR, USA); Annexin V-PI 
assay kit, BDOpt EIATMELISA set, Superscript first stand synthesis system was from Invitrogen (CA, USA); Cell 
Cycle Test Plus DNA reagent kit, 7-AAD and anti-SHP1 antibody were purchased from BD Pharmingen and BD 
Biosciences (CA, USA); UCP2 antibody was from SantaCruz Biotechnology (CA, USA). All other antibodies 
were purchased from Cell Signaling Technologies (USA). Mahanine was dissolved in 100% ethanol to make 
5000 μM for in vitro studies and dissolved in >5% DMSO for in vivo studies.
Inbred Balb/c mice (20–22 g) were housed in Institute Animal Facilities in CSIR-CDRI and fed a standard diet. 
All the animal-related experiments were performed in accordance with the National Regulatory Guidelines issued 
by Committee for the Purpose of Control And Supervision of Experiments on Animals (CPCSEA), Ministry of 
Environment and Forest, Govt. of India and used for experiments with prior approval from Institutional Animal 
Ethical Committee (IAEC)(IAEC approval no: IAEC/2015/42D).
Purification and characterization of mahanine. Mahanine, a carbazole alkaloid was purified from fresh 
leaves of an Indian medicinal plant, Murraya koenigii easily available throughout India. The purity and the struc-
ture of the isolated compound were established by different approaches like HPLC, LC-MS, 1[H] and13[C] NMR 
analysis as stated earlier10, 17 (Fig. 1a).
Parasite and cell culture. L. donovani sodium antimony gluconate (SAG) sensitive strain AG83 (MHOM/
IN/1983/AG83) originally isolated from an Indian patient with Kala-azar (ATCC® PRA413™) and SAG resistant 
GE1 (MHOM/IN/90/GE1) were maintained in M-199 medium supplemented with 10% heat-inactivated fetal 
calf serum (FCS, v/v) and gentamycin sulphate (200 µg/ml) at 22 °C39. To ensure the virulence, parasites were 
routinely passage through hamster. Murine macrophage cell line (J774A.1) was cultured in IMDM supplemented 
with 10% heat-inactivated FCS and antibiotic antimycotic solutions at 37 °C with 5% CO2.
Promastigote viability assay. Log phase L. donovani AG83 promastigotes (0.5 × 106/ml) were plated in 96 
well (200 µl/well) plate and incubated with a graded dose of mahanine (0–50 µM) for 24 and 48 hr respectively at 
22 °C. MTS (2.0 mg/ml) and PMS (0.92 mg/ml) were added (20 µl/well) in 5:1 ratio and further incubated for 3 hr 
at 37 °C. A number of formazan crystals formed were quantified by measuring the intensity of colour at 492 nm 
in an ELISA reader (Thermo Scientific), indicating the number of viable cells24. Control cells were exposed to the 
highest amount of the vehicle (0.15% absolute ethanol).
Promastigotes (2 × 106/ml) were incubated with mahanine (0–30 µM) for 24 hr at 22 °C. 7-AAD was added and 
further incubated in dark at 22 °C for 30 min according to the manufacturer’s instructions. Cells were acquired in 
a flow cytometer (BD FACSCalibur, BD Biosciences) by analyzing at least 1 × 104 cells with CellQuestPro software 
(BD FACSCalibur)40.
Annexin V-PI positivity. Mahanine-induced apoptosis was determined by annexinV-PI positivity as 
stated earlier with some modifications41. Log phase promastigotes (2 × 106/ml) were incubated with mahanine 
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(0–10 µM) for 24 hr at 22 °C. Cells were centrifuged, washed with PBS and suspended in annexin V binding 
buffer. Annexin V and PI then added according to the manufacturer’s instruction and incubated for 30 min in 
dark at 25 °C Acquisition was done in FACS and analyzed by CellQuestPro software.
DNA degradation assay. Mid-log phase promastigotes (1 × 107) were treated with mahanine (0–30 µM) 
for 24 hr and total DNA was extracted from treated and untreated cells using apoptotic DNA extraction kit as per 
manufacturer’s instructions, electrophoresed in 1% agarose gel and stained with ethidium bromide (0.50 µg/ml) in 
Tris-boric acid-EDTA (TBE) buffer. The image was visualized and photographed in Bio-Rad Gel Documentation 
system24.
Cell cycle analysis. Mahanine-induced cell cycle arrest was determined by cell cycle kit as stated earlier with 
some modifications12. Exponential phase parasites (2 × 106) were treated with mahanine (0–15 µM) for 24 hr at 
22 °C. They were harvested and processed using Cell Cycle Test Plus kit. At least 20,000 cells were acquired and 
the percentage of cells present in different phases of the cell cycle was determined by FACS. Data analyzed by 
CellQuestPro software.
Analysis of mitochondrial membrane potential. Mitochondrial membrane potential was measured 
using a cell permeable JC1 dye with some modifications41. Briefly, log phase promastigotes (2 × 106/ml) were 
incubated with mahanine (0–30 µM) for 24 hr at 22 °C. The cells were suspended in phosphate-buffered saline 
(PBS) and stained with the JC1 dye (2 µM/tube) for 10 min at 37 °C analyzed by flow cytometry.
Measurement of  intracel lular  reactive oxygen species (ROS) in promastig-
otes. Mahanine-induced intracellular ROS generation was measured by 2′7′- dichlorodihydro fluorescein 
diacetate acetyl ester (H2DCFDA) staining with some modifications24. For time kinetics, mid-log phase promas-
tigotes (2 × 106) were preloaded with H2DCFDA (50 µM) in PBS for 45 min at 37 °C in dark. Cells were washed 
and suspended in M199 medium supplemented with FCS. They were treated with the IC90 dose of mahanine 
(25 µM) for 0–1 hr at 22 °C in dark. For dose kinetics study, promastigotes were processed similarly and incu-
bated with mahanine (0–30 µM) for 45 min in dark. The inhibition of ROS generation was shown at the highest 
dose of mahanine by pretreatment of cells with NAC (2.5 mM) for 30 min. Cells were washed, suspended in PBS. 
Intracellular H2O2 was determined using flow cytometry by analyzing 10,000 cells.
Analysis of ROS-dependent death of promastigotes. Exponential phase promastigotes were 
suspended in M199 medium. One set of cells were pretreated with NAC (2.5 mM) for 30 min and washed. 
NAC-treated and untreated promastigotes were plated (2 × 106/well) in a six-well plate and incubated with maha-
nine (0–15 µM) for 24 hr at 22 °C. Cells were spin down, washed and suspended in PBS. PI (5.0 µg/ml) was added 
to 5.0 µl and incubated for 30 min in dark. Cells were washed, resuspended in PBS and acquired in FACS. Data 
was analyzed in CellQuestPro software42.
Effect of mahanine on amastigote in infected macrophage. Microscopic analysis of the effect of 
mahanine in intracellular amastigote number was carried out as described earlier43. J774A.1 (2 × 104) was seeded 
in glass coverslip and incubated for 48 hr at 37 °C incubator containing 5% CO2 for adherence. Cells were infected 
with stationary phase AG83 promastigotes at 1:10 (macrophage: parasite) ratio in for 4 hr at 37 °C. Non phagocy-
tosed parasites were removed, washed and infected J774A.1 cells were kept another 20 hr for multiplication of the 
parasite. Mahanine (0–20 µM) was added and incubated for another 24 hr. The medium was removed; coverslip 
was air-dried, fixed in methanol and Giemsa stained. The intracellular amastigote (100 macrophages/cover slip) 
was counted using a Zeiss microscope at 100X resolution in oil immersion.
Measurement of secreted cytokines in infected macrophages. J774A.1 cells were infected and 
treated with mahanine as described in the earlier paragraph in presence of LPS (2.5 µg/ml) for secretion of Th2 or 
PMA (25 ng/ml)-ionomycin (1.0 µg/ml) for Th1 cytokines overnight. Secreted cytokines (IFNγ, IL-4, and IL-10) 
was measured in the cell-free suspension by ELISA kit and the colour intensity was measured at 450 nm in ELISA 
reader43.
Western blot analysis. J774A.1 cells (1 × 106) were infected with promastigotes at 1: 10 at as stated earlier. 
Both uninfected and infected cells were incubated with mahanine (0–15 µM) for 24 hr. The cell lysate was pre-
pared and an equal amount of protein was separated in an SDS-PAGE (10%) and transferred to nitrocellulose 
membrane. The membrane was blocked with tris buffer saline (TBS)-BSA (2%) and incubated with the specific 
primary antibody (1:1000 dilutions) overnight at 4 °C followed by adding species specific HRP-conjugated sec-
ondary antibody (1:1000 dilutions). The signal was detected by West-pico ECL system (Pierce, Thermo Scientific, 
USA) as described earlier15.
L. donovani promastigotes (2 × 107) were treated with mahanine (0–20 µM) for 24 hr at 22 °C. The cell lysate 
was prepared and separated in 12% SDS-PAGE. Western blot was performed as stated above.
ROS generation by infected macrophages/splenocytes. Mahanine-induced ROS generation by 
infected macrophages was measured as stated previously with some modifications39. Briefly, J774A.1 cells (1 × 106 
cells/well) were infected with stationary phase promastigotes in 1:10 ratio for 4 hr in 37 °C. After the infection, 
non-ingested parasites were removed and infection was allowed for 20 hr in 37 °C. Then a graded dose of maha-
nine (0–15 µM) was added to infected and uninfected macrophages and further incubated for 24 hr at 37 °C. 
Macrophages were pellet down, washed and stained with H2DCFDA (10 µM) for 30 min at 37 °C and processed 
similarly.
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For in vivo, splenocytes isolated from all the experimental groups of mice were plated (1 × 106 cells/well) and 
incubated at 37 °C/5% CO2 for 72 hr in presence of SLA (soluble Leishmania antigen, 50 µg/ml). Splenocytes were 
then incubated with 10 μM H2DCFDA at 37 °C for 20 min and then analysed on fluorescence-activated cell sorter 
(FACS) Calibur flow cytometer (Becton Dickinson, USA) using a 530-nm filter44.
Nitric oxide (NO) measurement in the culture supernatant of infected macrophages/ spleno-
cytes. NO was measured by Griess reaction39. Briefly, J774A.1 cells (1 × 106/well) plated in a six-well plate and 
infected with stationary phase promastigotes at 1:10 ratio for 4 hr at 37 °C. After the infection, unbound parasites 
were washed out and infection was allowed for 20 hr at 37 °C. Mahanine (0-15 µM) was added to the wells and 
incubated for 24 hr. Culture supernatants were used to measure accumulated nitrite in the ELISA reader (Thermo 
Scientific) at 540 nm. Sodium nitrite (NaNO2) diluted in culture medium was used as a standard.
For in vivo, splenocytes from different experimental groups of Balb/c mice was prepared by Ficoll density 
gradient centrifugation and incubated for 3 days in 5% CO2 incubator at 37 °C in presence of soluble Leishmania 
antigen (SLA). NO generation was quantified by measuring the accumulation of nitrite in culture supernatants 
by Griess reagent45.
Molecular modeling studies. Target sequence and template identification. The amino acid sequences 
of all the antioxidant enzymes of L. donovani namely ascorbate peroxidase (H6V7N3_LEIDO), mitochondrial 
tryparedoxin peroxidise (A4ZZ67_LEIDO), cytoplasmic tryparedoxin peroxidase (A4ZZ66_LEIDO), Hsp83 
(HSP83_LEIDO), superoxide dismutases, namely, FeSODA (Q71S86_LEIDO) and FeSODB1 (Q71S88_LEIDO) 
were obtained from the UniProt database. For the template identification of these antioxidant enzymes for their 
3D structure prediction, BLASTp was performed taking the sequence of these proteins by searching against 
Protein Data Bank (PDB).The selected templates for these antioxidant enzymes are tabulated in Table 1.
Homology model building and refinement. The homology models of these enzymes were constructed using 
Modeller v9.1146, 47.For each enzyme, a total of 100 modeled structures were generated, based on the target 
sequence, target–template alignment information and 3D structure of the template proteins (from PDB). Spatial 
restrictions such as bond lengths, bond angles, dihedral angles and interactions between non-bonded residues 
were also considered and finally ranked them by the molecular probability density function (MolPdf) score. 
Sequential loop refinement was also performed using loop refinement tool after model building. The structure 
with the lowest MolPdf score was taken and was repeatedly energy minimized to get the lowest energy structure 
using Discovery Studio (Accelrys).
Model validation. The stereo-chemical quality of all the modeled structures of six antioxidant enzymes were 
evaluated by Ramachandran plot generated by RAMPAGE (http://mordred.bioc.cam.ac.uk/~rapper/rampage.
php,48, Verify3D49 and ERRAT50. Finally, the root means square deviation (RMSD) between the backbone of the 
template and the target was computed using the Struct program from Schrödinger.
Identification of binding sites. Using protein preparation wizard of Maestro package version 15.2 (from 
Schrödinger, LLC), the protonation state of the ionizable residues were fixed by using the Protein Preparation 
Wizard. In order to identify the binding pocket, the site recognition program SiteMap (Maestro 10.3.014) was run 
on all these modeled structures of six antioxidant enzymes51. This program calculates two types of scores for each 
site, namely SiteScore and Druggability score (Dscore). The putative binding pockets were selected on the basis of 
criteria that the Dscore was higher than 1.0.
Docking studies. The structure of mahanine was retrieved from PubChem, gastegier charges were added and 
typed with the cff91 force field. The structure was optimized with repeated energy minimization and molecular 
dynamics simulations using simulation module of Discovery Studio (Accelrys). Energy minimization was per-
formed alternately with steepest descent and conjugate gradient methods (200 steps each). Molecular dynamics 
simulation was done for 10,000 steps of 1 fs after 1000 steps of equilibration with a conformation sampling of one 
in 100 steps at 300 K. The optimized structure was used for docking studies. Molecular docking of mahanine with 
each of the antioxidant enzymes was performed using Autodock 4.252, 53. Protein structures were prepared by 
adding hydrogens. Non-polar hydrogens were merged and gastegier charges were assigned. Similarly, gastegier 
charges computed by Autodock tool were used on each atom of the ligand. AutoTors utility was used to define 
torsional degrees of freedom for the ligand. Autogrid was used to perform grid map settings. The grid was pre-
pared around the binding sites as predicted by SiteMap program with 88 × 80 × 80 Å cube and the spacing was 
at 0.375 Å. The lamarckian genetic algorithm was used to perform docking simulation, with an initial population 
of 150 randomly placed individuals, a maximum number of 2,50,000 energy evaluations, 1,50,000 generations, 
the mutation rate of 0.02, a cross over rate of 0.8 and an elitism value of 1 were used. 100 docking runs were 
performed. Pseudo-Solis and Wets algorithm was used for local search method. Finally, the resulting docked con-
formations were clustered together on the basis of RMSD tolerance of 1.5 Å and represented by a most favourable 
free energy of binding.
Genetic expression profiling APX in promastigotes. Log phase L. donovani AG83 promastigotes 
(1 × 107/ml) were treated with mahanine (0–20 µM) for 24 hr in 22 °C. Total RNA was isolated from promas-
tigote by using Lipid Tissue RNA isolation Kit. RNA was transcribed to cDNA and the specific primers for the 
gene of APX (forward, 5′CTGTACGAGGGTAACAAAGG3′; reverse, 5′ATCAGCTGCATCTTCTCAAC3′) and 
α-tubulin (forward, 5′CATCTACGACCTCACTCGTC3′; reverse, 5′GACAATTCAGTTCGTGGACT3′) was 
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used for amplification in RT-PCR. The reaction product was separated in 1% agarose gel stained with ethidium 
bromide and image captured in Bio-Rad Gel Documentation system54, 55.
Efficacy of mahanine in Leishmania-infected acute murine model. Female Balb/c mice (4–6 weeks) 
were infected with stationary phase AG83 promastigotes (1 × 107) suspended in PBS by lateral tail vain. After 15 
days post-infection, animals were selected for subsequent experiments45.
Three groups of mice, each containing 5 animals was used for treatment with mahanine. Group I mice was 
fed with PBS only as vehicle control, while group II and III received 20 mg/Kgb.w/day and 40 mg/Kgb.w/day 
mahanine for 5 consecutive days respectively and sacrificed after 4 days post-feeding. Standard drug miltefosine 
was used as a reference at 30 mg/Kgb.w/day for 5 consecutive days similarly. Parasite burden was calculated in 
Leishman-Donovan Unit (LDU), LDU = amastigote per nucleated cell × organ weight in milligram45.
T cell proliferation assay. T cell proliferation assay was performed as described earlier55. Briefly, isolated 
splenocytes (1 × 105/well) from mice were plated 96-well plate and incubated for 3 days at 37 °C/5% CO2 for 
proliferation. Next, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT, 1.0 mg/ml/well) was 
added and further incubated for 4 hr. Resultant formazan crystals were dissolved in DMSO and the colour inten-
sity was determined in ELISA reader at 492 nm.
Real-time PCR analysis of cytokines. Total RNA was isolated from infected and uninfected mice sple-
nocytes by using an RNeasy mini kit as described previously. cDNA was synthesized using RNA (1.0 mg) as a 
template; real-time PCR analysis was performed by mixing cDNA with SYBR Green PCR Master mix and ampli-
fied using primers specific for genes encoding cytokines IL-12 (forward, 5′ TATGTTGTAGAGGTGGACTG 
3′; reverse, 5′ TTGTGGCAGGTGTATTGG 3′) and iNOS (forward, 5′ CGACGGCACCATCAGAGG 3′; 
reverse, 5′ AGGATCAGAGGCAGCACATC 3′) in Roche Applied Science light cycler 480.0. Relative quan-
tification of each target genes was normalized to mRNA level of a housekeeping gene (HGPRT-forward, 5′ 
GATAGATCCACTCCCATAACTG 3′; reverse, 5′ TACCTTCAACAATCAAGACATTC 3′) and expressed as a 
fold change compared with uninfected control using the comparative cycle threshold (CT) method45.
Statistical analysis. Data represented are the mean ± standard error of the mean for three independent 
experiments. Data were analyzed by one-way ANOVA using GraphPad Prism software (version 5.1). Student’s 
t-test was performed to measure the statistical significance of differences between a pair of data sets. Differences 
in p- values of ≤0.05 between treatment groups were considered significant.
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